The FDA believes that the company, which has enjoyed great success with its electronic cigarettes and flavored refills, has failed to demonstrate that the commercialization of its products complies with public health protection rules.
–
Juul Labs said in a statement that it disagreed with the FDA’s conclusion and said it had provided sufficient data to resolve the issues raised by the agency. The company will now appeal the decision, it said.
–
Related posts:
Eleva Acquires Global Rights for Liver Cancer Treatment Drug – Camrelizumab: HLB's Strategic Move in...
Nilüfer Gündoğan files charges against Volt for libel and slander | Inland
Block in constructing permits for 2 years in Athens - The cutter
- 2024-07-12 05:05:06
Starting a new growth stage, 6 stocks that are expected to rise in "highest profit revival & value s...